China Deep Brain Stimulation Devices Market Size & Outlook
China deep brain stimulation devices market, 2018-2030 (US$M)
Related Markets
China deep brain stimulation devices market highlights
- The China deep brain stimulation devices market generated a revenue of USD 25.1 million in 2024 and is expected to reach USD 47.7 million by 2030.
- The China market is expected to grow at a CAGR of 11.4% from 2025 to 2030.
- In terms of segment, dystonia was the largest revenue generating application in 2024.
- Epilepsy is the most lucrative application segment registering the fastest growth during the forecast period.
Deep brain stimulation devices market data book summary
| Market revenue in 2024 | USD 25.1 million |
| Market revenue in 2030 | USD 47.7 million |
| Growth rate | 11.4% (CAGR from 2025 to 2030) |
| Largest segment | Dystonia |
| Fastest growing segment | Epilepsy |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
| Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Other key industry trends
- In terms of revenue, China accounted for 1.8% of the global deep brain stimulation devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan deep brain stimulation devices market is projected to lead the regional market in terms of revenue in 2030.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 17.8 million by 2030.
Dystonia was the largest segment with a revenue share of 71.31% in 2024. Horizon Databook has segmented the China deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
According to Population Reference Bureau (PRB), the number of people belonging to the age group of 65 and above in China may increase to more than 300 million by 2050. Furthermore, China is developing cost-effective devices for individuals suffering from brain-associated diseases.
For instance, a China-based company called PINS Medical has developed a brain stimulation device commonly known as a brain pacemaker. PINS Medical was the first company to obtain a CE mark and has helped a number of individuals with movement disorders such as PD.
Therefore, such advancements in brain stimulation devices are likely to aid in creating growth opportunities in China deep brain stimulation devices market. The market may witness significant growth owing to strategic collaborations with global players for development as well as marketing of these devices due to the presence of high untapped opportunities in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Deep Brain Stimulation Devices Market Scope
Deep Brain Stimulation Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China deep brain stimulation devices market size, by application, 2018-2030 (US$M)
China Deep Brain Stimulation Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
